Drug History: MAXALT

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	MAXALT
FDA Application No:	(NDA) 020864
Active Ingredient(s):	RIZATRIPTAN BENZOATE
Company:	MERCK

Label History

View the label approved on June 29, 1998 for MAXALT, (NDA) 020864

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
12/6/2001	009	Manufacturing Change or Addition
4/22/2002	008	Labeling Revision	Letter
12/11/2000	007	Labeling Revision	Review
1/25/2001	006	Manufacturing Change or Addition
12/11/2000	005	Efficacy Supplement with Clinical Data to Support	Review
12/11/2000	004	Labeling Revision	Review
11/16/1999	003	Efficacy Supplement with Clinical Data to Support	Letter
6/21/2000	002	Efficacy Supplement with Clinical Data to Support	Review
6/29/1998	000	Approval	Letter Label Review Other Important Information from FDA

There are no Therapeutic Equivalents